Advances in liposome research in the field of antitumor

Liposomes, as biocompatible and safe nanocarriers with easily modified surfaces, can be well used in the field of antitumor. Their targeting properties have contributed to reduction drug dosage non-target cell toxicity. To further exploit liposomes, passive active liposomes physicochemical been constructed by surface modification. This paper summarizes mechanisms action different types targeted describes specific role overcoming tumor resistance, immunotherapy helping drugs cross blood-brain barrier, current development issues future directions.